Jie Ji

834 total citations
43 papers, 338 citations indexed

About

Jie Ji is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Jie Ji has authored 43 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 11 papers in Genetics and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Jie Ji's work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). Jie Ji is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). Jie Ji collaborates with scholars based in China, United States and France. Jie Ji's co-authors include Xuan Deng, Qi‐qiang He, Ying Wang, Yujian Liu, Jane Huang, Yuqin Song, Haiyan Yang, Jie Jin, Keshu Zhou and Ru Feng and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Jie Ji

33 papers receiving 334 citations

Peers

Jie Ji
Comparison fields: 5 of 78
  • Pathology and Forensic Medicine 122
  • Oncology 97
  • Genetics 89
  • Molecular Biology 67
  • Physiology 48
Replace Eduardus F. M. Posthuma with:
Eduardus F. M. Posthuma Netherlands
Michael Gilbertson Australia
Hans Bentzen Denmark
Maria L. Mace Denmark
Jo‐Fen Liu United Kingdom
Masayuki Yao Japan
Özkan Sayan Türkiye
Juana Oramás Spain
R.M. Pickering United Kingdom
Richard A. Lutes United States
Eduardus F. M. Posthuma Netherlands View profile →
Citations per field, relative to Jie Ji
Jie Ji · 1×
Citations per year, relative to Jie Ji
Jie Ji · 1×

Countries citing papers authored by Jie Ji

Since Specialization
Citations

This map shows the geographic impact of Jie Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Ji more than expected).

Fields of papers citing papers by Jie Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Ji. The network helps show where Jie Ji may publish in the future.

Co-authorship network of co-authors of Jie Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Ji. A scholar is included among the top collaborators of Jie Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Ji. Jie Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 8
4 1
5 0
6 4
7 0
8 1
9 2
10 1
11 5
12 0
13 6
14 4
15 111
16 3
17 7
18 0
19 1
20
The efficacy of heparin in maintaining the patency of peripherally inserted central catheters in neonates:a meta-analysis
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026